Jim Tartaglia

6.2k total citations
19 papers, 897 citations indexed

About

Jim Tartaglia is a scholar working on Virology, Immunology and Epidemiology. According to data from OpenAlex, Jim Tartaglia has authored 19 papers receiving a total of 897 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Virology, 12 papers in Immunology and 7 papers in Epidemiology. Recurrent topics in Jim Tartaglia's work include HIV Research and Treatment (14 papers), Immune Cell Function and Interaction (8 papers) and Immunotherapy and Immune Responses (6 papers). Jim Tartaglia is often cited by papers focused on HIV Research and Treatment (14 papers), Immune Cell Function and Interaction (8 papers) and Immunotherapy and Immune Responses (6 papers). Jim Tartaglia collaborates with scholars based in United States, France and Canada. Jim Tartaglia's co-authors include Genoveffa Franchini, Sanjay Gurunathan, János Nacsa, Elżbieta Tryniszewska, Mariano Estéban, Giuseppe Pantaleo, Bertram L. Jacobs, Lynn Baglyos, Stanley A. Plotkin and Zdeněk Hel and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and The Journal of Immunology.

In The Last Decade

Jim Tartaglia

19 papers receiving 880 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jim Tartaglia United States 16 601 545 286 230 202 19 897
Adam P. Buzby United States 12 679 1.1× 524 1.0× 263 0.9× 212 0.9× 222 1.1× 16 848
Annalena La Porte United States 8 553 0.9× 451 0.8× 242 0.8× 320 1.4× 204 1.0× 11 864
Georgia R. Krivulka United States 11 776 1.3× 644 1.2× 256 0.9× 297 1.3× 283 1.4× 11 1.0k
Zimra R. Israel United States 16 539 0.9× 489 0.9× 304 1.1× 206 0.9× 236 1.2× 21 888
Natalia Kozyr United States 13 813 1.4× 704 1.3× 334 1.2× 140 0.6× 254 1.3× 16 1.1k
Barry Walker United Kingdom 15 397 0.7× 446 0.8× 347 1.2× 218 0.9× 418 2.1× 25 912
Kristin Beaudry United States 13 1.1k 1.8× 838 1.5× 334 1.2× 359 1.6× 351 1.7× 13 1.4k
Nathan Whizin United States 3 718 1.2× 756 1.4× 521 1.8× 242 1.1× 288 1.4× 4 1.2k
Carlos de Noronha United States 3 887 1.5× 444 0.8× 320 1.1× 284 1.2× 466 2.3× 5 1.1k
Kelli Oswald United States 5 811 1.3× 784 1.4× 552 1.9× 247 1.1× 347 1.7× 7 1.3k

Countries citing papers authored by Jim Tartaglia

Since Specialization
Citations

This map shows the geographic impact of Jim Tartaglia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jim Tartaglia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jim Tartaglia more than expected).

Fields of papers citing papers by Jim Tartaglia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jim Tartaglia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jim Tartaglia. The network helps show where Jim Tartaglia may publish in the future.

Co-authorship network of co-authors of Jim Tartaglia

This figure shows the co-authorship network connecting the top 25 collaborators of Jim Tartaglia. A scholar is included among the top collaborators of Jim Tartaglia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jim Tartaglia. Jim Tartaglia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Ford, Emily S., Alvason Zhenhua Li, Kerry J. Laing, et al.. (2024). Expansion of the HSV-2–specific T cell repertoire in skin after immunotherapeutic HSV-2 vaccine. JCI Insight. 9(14). 3 indexed citations
2.
Sridhar, Saranya, Roman M. Chicz, William H. Warren, et al.. (2022). The potential of Beta variant containing COVID booster vaccines for chasing Omicron in 2022. Nature Communications. 13(1). 5794–5794. 8 indexed citations
3.
Robb, Merlin L., Supachai Rerks‐Ngarm, Sorachai Nitayaphan, et al.. (2012). Risk behaviour and time as covariates for efficacy of the HIV vaccine regimen ALVAC-HIV (vCP1521) and AIDSVAX B/E: a post-hoc analysis of the Thai phase 3 efficacy trial RV 144. The Lancet Infectious Diseases. 12(7). 531–537. 127 indexed citations
4.
Perreau, Matthieu, Hugh C. Welles, Alexandre Harari, et al.. (2011). DNA/NYVAC Vaccine Regimen Induces HIV-Specific CD4 and CD8 T-Cell Responses in Intestinal Mucosa. Journal of Virology. 85(19). 9854–9862. 27 indexed citations
5.
Pantaleo, Giuseppe, Mariano Estéban, Bertram L. Jacobs, & Jim Tartaglia. (2010). Poxvirus vector-based HIV vaccines. Current Opinion in HIV and AIDS. 5(5). 391–396. 62 indexed citations
6.
Bett, Andrew J., Sheri Dubey, Devan V. Mehrotra, et al.. (2010). Comparison of T cell immune responses induced by vectored HIV vaccines in non-human primates and humans. Vaccine. 28(50). 7881–7889. 21 indexed citations
7.
Hel, Zdeněk, Wen-Po Tsai, Elżbieta Tryniszewska, et al.. (2006). Improved Vaccine Protection from Simian AIDS by the Addition of Nonstructural Simian Immunodeficiency Virus Genes. The Journal of Immunology. 176(1). 85–96. 49 indexed citations
8.
9.
Lehner, Thomas, Michael Höelscher, Mario Clerici, et al.. (2005). European Union and EDCTP strategy in the global context: Recommendations for preventive HIV/AIDS vaccines research. Vaccine. 23(48-49). 5551–5556. 8 indexed citations
10.
Betts, Michael R., David A. Price, Anju Bansal, et al.. (2005). Characterization of functional and phenotypic changes in anti-Gag vaccine-induced T cell responses and their role in protection after HIV-1 infection. Proceedings of the National Academy of Sciences. 102(12). 4512–4517. 105 indexed citations
11.
Ferrari, Guido, Janet Ottinger, Bradley H. Edwards, et al.. (2004). Absence of Immunodominant Anti-Gag p17 (SL9) Responses among Gag CTL-Positive, HIV-Uninfected Vaccine Recipients Expressing the HLA-A*0201 Allele. The Journal of Immunology. 173(3). 2126–2133. 24 indexed citations
12.
Tine, John A., Hüseyin Firat, Anne F. Payne, et al.. (2004). Enhanced multiepitope-based vaccines elicit CD8+ cytotoxic T cells against both immunodominant and cryptic epitopes. Vaccine. 23(8). 1085–1091. 22 indexed citations
13.
Franchini, Genoveffa, Sanjay Gurunathan, Lynn Baglyos, Stanley A. Plotkin, & Jim Tartaglia. (2004). Poxvirus-based vaccine candidates for HIV: two decades of experience with special emphasis on canarypox vectors. Expert Review of Vaccines. 3(sup1). S75–S88. 74 indexed citations
14.
Casimiro, Danilo R., Andrew J. Bett, Tong‐Ming Fu, et al.. (2004). Heterologous Human Immunodeficiency Virus Type 1 Priming-Boosting Immunization Strategies Involving Replication-Defective Adenovirus and Poxvirus Vaccine Vectors. Journal of Virology. 78(20). 11434–11438. 81 indexed citations
15.
Nacsa, János, Antonia Radaelli, Yvette Edghill‐Smith, et al.. (2003). Avipox-based simian immunodeficiency virus (SIV) vaccines elicit a high frequency of SIV-specific CD4+ and CD8+ T-cell responses in vaccinia-experienced SIVmac251-infected macaques. Vaccine. 22(5-6). 597–606. 23 indexed citations
16.
Tryniszewska, Elżbieta, János Nacsa, Mark G. Lewis, et al.. (2002). Vaccination of Macaques with Long-Standing SIVmac251 Infection Lowers the Viral Set Point After Cessation of Antiretroviral Therapy. The Journal of Immunology. 169(9). 5347–5357. 79 indexed citations
17.
18.
Sambhara, Suryaprakash, Renata Lima de Miranda, Olive James, et al.. (2001). Severe Impairment of Primary but Not Memory Responses to Influenza Viral Antigens in Aged Mice: Costimulation in Vivo Partially Reverses Impaired Primary Immune Responses. Cellular Immunology. 210(1). 1–4. 34 indexed citations
19.
Tartaglia, Jim, Marie-Claude Bonnet, Neil L. Berinstein, et al.. (2001). Therapeutic vaccines against melanoma and colorectal cancer. Vaccine. 19(17-19). 2571–2575. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Adam P. Buzby Breakdown of academic impact, for papers by Annalena La Porte Breakdown of academic impact, for papers by Georgia R. Krivulka Breakdown of academic impact, for papers by Zimra R. Israel Breakdown of academic impact, for papers by Natalia Kozyr Breakdown of academic impact, for papers by Barry Walker Breakdown of academic impact, for papers by Kristin Beaudry Breakdown of academic impact, for papers by Nathan Whizin Breakdown of academic impact, for papers by Carlos de Noronha Breakdown of academic impact, for papers by Kelli Oswald
Rankless by CCL
2026